Skip to main content

News and blog posts

01
Mar 2024

Publication Digest: Barriers and Facilitators in Pricing and Funding Policies of European Countries That Impact the Use of Point-of-Care Diagnostics for Acute Respiratory Tract Infections in Outpatient Practices

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Steigenberger et al. investigated barriers and facilitators in health technology assessment (HTA), pricing, and funding policies pertaining to the utilization of rapid point-of-care diagnostics for patients with community-acquired acute respiratory tract infections. The authors conducted expert interviews with representatives from five European countries and identified key challenges, such as the lack of evidence and limited transferability of methods from drug-based HTA to diagnostics, alongside pricing barriers due to the absence of price regulation and weak purchasing power. They underscored the importance of optimized peri-launch policies to enhance the adoption of point-of-care tests.
01
Mar 2024

Recommendations about add-on reimbursement for medical devices in France in February 2024

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in February 2024. Fourteen recommendations were published concerning the registration of medical devices or modification of registration conditions with the extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular, neurovascular, neuromodulation, endocrine, and endoscopy devices, as well as medical aids.
29
Feb 2024

Publication Digest: Institute for Clinical and Economic Review - Peterson Health Technology Institute value assessment framework for digital health technologies

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Pearson et al. proposed a novel value assessment framework for digital health technologies (DHTs). Given the diversity of DHT modalities and the lack of standard regulatory and payer pathways, the authors aimed to establish evidence standards tailored specifically for DHTs, guiding technology developers in generating robust evidence. This framework can help organizations in adopting high-impact DHTs with the strongest evidence for delivering improved clinical outcomes and cost savings.
28
Feb 2024

Rapid HTAs of four medical devices released in Tuscany

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 2935 of February 13, 2024, Tuscany Regional Healthcare has published assessments of four medical devices in the cardiovascular and peripheral vascular, ICU/OR, pulmonary and airways, dermatology, and robotic surgery areas.
27
Feb 2024

Med Tech-related health technology assessments from NIHR in January 2024

In January 2024, the National Institute for Health and Care Research (NIHR) in England released one Med Tech-related assessment in its Health Technology Assessment (HTA) Journal, which concerned bariatric surgery in adults with severe obesity in Scotland. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.
26
Feb 2024

Three new recommendations by the Danish Health Technology Council

In February 2024, the Danish Health Technology Council (Behandlingsrådet) completed three assessments. The Council made positive recommendations regarding home non-invasive ventilation for patients with COPD and non-surgical management for the treatment of distal radius fractures in patients over 65 years. Guided internet-based cognitive behavioral therapy for the treatment of adults with mild or moderate depression was not recommended.
26
Feb 2024

Watch new short videos on the MTRC YouTube channel

MTRC released several short (2-4 minutes) educational videos on its YouTube channel: “Three common market access barriers for medical technologies”, “Reimbursement models and incentives for healthcare providers”, “How to spot a well-functioning DRG system?” and “Market access challenges for different types of medical technologies”. Videos can be of interest to an audience of both market access professionals and those new to the field of reimbursement, funding, HTA and market access for medical technologies in Europe.
23
Feb 2024

Publication Digest: Digital health applications from a government-regulated directory of reimbursable health apps in Germany – a systematic review for evidence and bias

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Dittrich et al. conducted a systematic review to assess the evidence quality and manufacturers' approaches regarding digital health applications (DiGA) in Germany following the Digital Healthcare Act. The results revealed evidence-related gaps, such as the relatively low quality of most of the available studies for inclusion in the DiGA directory with high potential for bias and limited external generalizability. The authors highlighted the need for addressing found evidence gaps and further studies of higher quality to improve the evidence base concerning the benefits of prescribable apps.
22
Feb 2024

NHS Cancer Programme Innovation Open Call 3 announced in England

On January 26, 2024, NHS England announced the third round of the Innovation Open Call, funded by the NHS Cancer Programme. All types of late-stage innovations aimed at early detection and diagnosis of cancer are eligible, including medical devices, in-vitro diagnostics, digital health solutions, and AI. Awarded projects will be 100% funded up to the total value of £4 million to produce and evaluate evidence in a real-world setting, supporting adoption and spread by providers, commissioners, and regulators. The application submission will be open on April 8, 2024.